Literature DB >> 6207107

Characterization of monoclonal antibodies to Streptococcus mutans antigenic determinants I/II, I, II, and III and their serotype specificities.

R Smith, T Lehner, P C Beverley.   

Abstract

Monoclonal antibodies (McAb) were developed to four protein components of Streptococcus mutans serotype c, some of which are significant in the protection against dental caries. The six McAb used in this investigation support the identities of streptococcal antigens (SA) I/II, I, II, and III. The specificities of these antigenic determinants were established both by direct binding and inhibition with the pure SA with a solid-phase radioassay. Whereas conventional antisera to S. mutans serotype c cross-react with serotypes c, e, and f (and g), McAb to serotype c-derived SA I/II react predominantly with serotype c and show some low-titer reactivity with serotype f. The slight cross-reactivity between S. mutants cells of serotypes c and f could be further differentiated by absorption of any of the three McAb to SA I/II with cells of serotype c. Parallel studies of McAb with cells of S. mutans and their ammonium sulfate-precipitated culture supernatants suggest that some SA determinants are retained predominantly on the cell surface, but others are readily shed into the culture medium, so that they are detected both on the cell surface and culture medium. Unlike polyclonal antibodies, McAb are capable of discriminating single antigenic determinants and can be applied to the study of shedding of antigens from microorganisms into the environment, such as the gut or gingival sulcus.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6207107      PMCID: PMC261438          DOI: 10.1128/iai.46.1.168-175.1984

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Continuous cultures of fused cells secreting antibody of predefined specificity.

Authors:  G Köhler; C Milstein
Journal:  Nature       Date:  1975-08-07       Impact factor: 49.962

2.  Antigens from Actinomyces species and their value in identification.

Authors:  G H Bowden; J M Hardie; E D Fillery
Journal:  J Dent Res       Date:  1976-01       Impact factor: 6.116

3.  Purification of dextran-binding protein from cariogenic Streptococcus mutans.

Authors:  M M McCabe; R M Hamelik; E E Smith
Journal:  Biochem Biophys Res Commun       Date:  1977-09-09       Impact factor: 3.575

4.  Characterisation of antigens extracted from cells and culture fluids of Streptococcus mutans serotype c.

Authors:  M W Russell; T Lehner
Journal:  Arch Oral Biol       Date:  1978       Impact factor: 2.633

5.  Biochemical and serological properties of Streptococcus mutans from various human and animal sources.

Authors:  B Perch; E Kjems; T Ravn
Journal:  Acta Pathol Microbiol Scand B Microbiol Immunol       Date:  1974-06

6.  Extracellular glucosyltransferase activity of an HS strain of Streptococcus mutans.

Authors:  B Guggenheim; E Newbrun
Journal:  Helv Odontol Acta       Date:  1969-10

7.  Purification and properties of dextransucrase from Streptococcus sanguis.

Authors:  J Carlsson; E Newbrun; B Krasse
Journal:  Arch Oral Biol       Date:  1969-05       Impact factor: 2.633

8.  Fusion between immunoglobulin-secreting and nonsecreting myeloma cell lines.

Authors:  G Köhler; S C Howe; C Milstein
Journal:  Eur J Immunol       Date:  1976-04       Impact factor: 5.532

9.  Demonstration of five serological groups of streptococcal strains resembling Streptococcus mutans.

Authors:  D Bratthall
Journal:  Odontol Revy       Date:  1970

10.  Wall-associated protein antigens of Streptococcus mutans.

Authors:  R R Russell
Journal:  J Gen Microbiol       Date:  1979-09
View more
  20 in total

1.  Identification of mutans streptococci with monoclonal antibodies.

Authors:  J J de Soet; P J van Dalen; R R Russell; J de Graaff
Journal:  Antonie Van Leeuwenhoek       Date:  1990-11       Impact factor: 2.271

2.  Sequence and structural analysis of surface protein antigen I/II (SpaA) of Streptococcus sobrinus.

Authors:  R J LaPolla; J A Haron; C G Kelly; W R Taylor; C Bohart; M Hendricks; J P Pyati; R T Graff; J K Ma; T Lehner
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

3.  Conservation of the gene encoding streptococcal antigen I/II in oral streptococci.

Authors:  J K Ma; C G Kelly; G Munro; R A Whiley; T Lehner
Journal:  Infect Immun       Date:  1991-08       Impact factor: 3.441

4.  Proteolysis of the 185,000 MW streptococcal cell wall antigen generating 4000 and 6000 MW peptides with distinct antigenic determinants.

Authors:  C G Mitchell; T Lehner
Journal:  Immunology       Date:  1989-02       Impact factor: 7.397

5.  Helper and suppressor functions of human mononuclear cells depleted of antigen-binding T8+ cells.

Authors:  T Lehner; J Avery; R Smith
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

6.  Immunological cross-reactivity between Streptococcus mutans and human heart tissue examined by cross-immunization experiments.

Authors:  H Y Wu; M W Russell
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

7.  Antigenic characterization of fimbria preparations from Streptococcus mutans isolates from caries-free and caries-susceptible subjects.

Authors:  M Perrone; L E Gfell; M Fontana; R L Gregory
Journal:  Clin Diagn Lab Immunol       Date:  1997-05

8.  Local passive immunization by monoclonal antibodies against streptococcal antigen I/II in the prevention of dental caries.

Authors:  T Lehner; J Caldwell; R Smith
Journal:  Infect Immun       Date:  1985-12       Impact factor: 3.441

9.  A protein fragment of streptococcal cell surface antigen I/II which prevents adhesion of Streptococcus mutans.

Authors:  G H Munro; P Evans; S Todryk; P Buckett; C G Kelly; T Lehner
Journal:  Infect Immun       Date:  1993-11       Impact factor: 3.441

10.  Molecular cloning and expression of a Streptococcus mutans major surface protein antigen, P1 (I/II), in Escherichia coli.

Authors:  S F Lee; A Progulske-Fox; A S Bleiweis
Journal:  Infect Immun       Date:  1988-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.